| Parallel imports, price controls, and innovation M Reisinger, L Saurí, H Zenger Journal of Health Economics 66, 163-179, 2019 | 16 | 2019 |
| Generic entry in prescription medicines in the EU: main characteristics, determinants and effects E Glowicka, S Lorincz, E Pesaresi, LS Romero, V Verouden Brussels: European Commission, 2009 | 15 | 2009 |
| Recent developments at DG competition: 2018/2019 R Kotzeva, D Kovo, S Lorincz, G Sapi, L Sauri, T Valletti Review of Industrial Organization 55, 551-578, 2019 | 12 | 2019 |
| Recent developments at DG competition: 2015/2016 A Claici, D Coublucq, G Federico, M Motta, L Saurí Review of Industrial Organization 49, 585-611, 2016 | 5 | 2016 |
| Industrial Policies, Competition, and Efficiency: The Need for State Aid Control J Piechucka, L Saurí-Romero, B Smulders Journal of Competition Law & Economics, nhad014, 2023 | 3 | 2023 |
| Desarrollos Recientes en la Política de la Competencia en el Sector Farmacéutico: Más Competencia para una mayor inversión en Innovación y para un mejor acceso a los fármacos L Saurí Papeles de Economía Española, 197, 2015 | 2 | 2015 |
| Consideraciones de equidad en la distribución personal de salud L Sauri, JC Font Revista de administración sanitaria siglo XXI 1 (4), 575-591, 2003 | 1 | 2003 |
| Recent Developments at DG Competition: 2021/2022 T Buettner, D Coublucq, R Kotzeva, L Sauri-Romero, P Régibeau Review of Industrial Organization 61 (4), 449-487, 2022 | | 2022 |
